Final results of a phase-III-study of concurrent versus sequential thoracic radiotherapy (TRT) in combination with cisplatin (P) and etoposide (E) for limited-stage small cell lung cancer (LD-SCLC). The Japan Clinical Oncology Group (JCOG) Study. - Goto,K.; Nishiwaki,Y.; Takada,M.; Fukuoka,M.; Kawahara,M.; Sugiara,T.; Kurita,Y.; Watanabe,K.; Noda,K.; Yoshimura,K.; Tamura,T.; Saijo,N. (Proc Am Soc Clin Oncol, 1999)